Involvement of Asymmetric Dimethylarginine in Senescence of Endothelial Progenitor Cells from Type 1 Diabetes Mellitus Rat Bone Marrow
Author:
  • Article
  • | |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • | |
  • Comments
    Abstract:

    imTo explore the relationship of asymmetric dimethylarginine (ADMA)and senescence of endothelial progenitor cells (EPC) in type 1 diabetic rats.MethodsThe rat model of type 1 diabetes mellitus was established by intraperitoneal injection of streptozotocin (STZ, 65 mg/kg) for one time.The concentration of fasting blood glucose, the level of ADMA in plasma, the percentage of senescence of EPC from bone marrow and the mRNA expression of dimethylarginine dimethylaminohydrolase 2 (DDAH2) and SIRT1 were detected.ResultsThe senescence percentage of EPC(39 % ± 8 % vs 11 %±2%) and the level of ADMA (0.67± 0.06 μmol/L vs 0.55± 0.07 μmol/L )in plasma were increased and the expression of DDAH2 and SIRT1 mRNA were down-regulated (0.56 ± 0.17 vs 1.00 ± 0.22,0.08 ± 0.17 vs 1.00 ± 0.39).ConclusionThe senescence of EPC was related with the increased level of ADMA in plasma, which may involve the SIRT1/DDAH2 pathway.

    Reference
    Related
    Cited by
Get Citation

YUAN Qiong, WU Yan, LIU Si-Yu, HU Chang-Ping, PENG Jun,,LI Yuan-Jian. Involvement of Asymmetric Dimethylarginine in Senescence of Endothelial Progenitor Cells from Type 1 Diabetes Mellitus Rat Bone Marrow[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2010,18(2):95-98.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:January 25,2010
  • Revised:February 18,2010
Article QR Code